American Express Company filings document the regulatory record of a global payments company with consumer, small-business, commercial, and merchant-network activities. Current reports and Regulation FD disclosures cover operating results, supplemental financial data, Card Member loan delinquency and write-off statistics for U.S. Consumer and U.S. Small Business portfolios, and risk disclosures tied to spending volumes, partnerships, regulation, litigation, competition, and reputation.
Its filings also address capital structure and governance, including fixed-to-floating rate note issuances under shelf registration materials, common-share dividend actions, annual meeting voting results, director elections, auditor ratification, executive compensation votes, shareholder proposals, and related proxy disclosures.
Stephen J. Squeri, American Express Chairman and CEO, exercised options covering 299,401 shares at a $148.45 per-share exercise price on November 4, 2026, acquiring 299,401 common shares. He sold 299,401 shares that day in four transactions at weighted-average prices of $330.52, $331.64, $332.42 and $332.98. No Rule 10b5-1 plan is reported.
The reported position in these options after exercise was 0. Separate positions listed were 130 shares in a 401(k) Trust under the Company’s Retirement Savings Plan and 163,292 shares through Stephen J. Squeri 2025 Master GRAT.
American Express Co. (AXP) is identified as the issuer associated with a Form 13F holdings report submitted by institutional investment manager American Express. The report summary lists one information-table entry and a total information-table value of $0, rounded to the nearest dollar.
American Express Company (AXP) officer Stephen J. Squeri reported a planned sale of 299,401 common shares. The notice lists an aggregate market value of $99,448,587.06, 670,552,018 shares outstanding, and an approximate sale date of November 4, 2026. Morgan Stanley Smith Barney LLC is listed as broker, and NYSE as the exchange.
American Express (AXP) Chairman and CEO Stephen J. Squeri had 74,850 employee stock options vest on October 31, 2026. The vesting represented the remaining 25% of Performance Stock Options granted in October 2022, based on satisfaction of the award’s performance criteria and his continued employment through October 31, 2026. The options have a $148.45 exercise price and expire on October 31, 2029; the reported option position following the transaction was 299,401.
American Express Co. Chief Legal Officer Laureen Seeger exercised options covering 69,860 common shares at an exercise price of $148.45 per share; the options list October 31, 2026 as the exercise date, while the reported transaction is dated November 2, 2026. She acquired 69,860 shares and sold the same number on November 2 at a weighted average price of $328.17 per share. The sale transactions ranged from $327.60 to $328.51 per share, and no Rule 10b5-1 plan is reported.
Separately, 17,465 Performance Stock Options vested on October 31, 2026, representing the remaining 25% of an award granted in October 2022. Vesting was based on the award's specified performance criteria and continued employment through October 31, 2026. The options have a $148.45 exercise price and an October 31, 2029 expiration date.
American Express Co. reported that Denise Pickett, Pres., Enterprise Shared Serv., vested 17,465 Performance Stock Options on October 31, 2026. This represented the remaining 25% of options granted in October 2022 and was tied to satisfaction of the award's performance criteria and her continued employment through October 31, 2026. The options have a $148.45 exercise price; her reported option holdings after vesting were 69,860, and the options expire October 31, 2029.
American Express Co. Group Pres., GMNS Anna Marrs reported exercising options for 44,910 common shares at a $148.45 exercise price and selling 44,910 shares on November 2, 2026. The three sales were 14,630 shares at a weighted-average $326.63, 16,833 at $327.25, and 13,447 at $327.77. A separate 22,455 Performance Stock Options vested October 31, 2026, representing the remaining 25% of an October 2022 award, based on the award's performance criteria and continued employment through that date.
American Express Co. officer Raymond Joabar, Grp. Pres., Global Comm. Serv., had 22,455 Performance Stock Options vest on October 31, 2026, representing the remaining 25% of his October 2022 award. The vesting followed satisfaction of the award’s performance criteria and his continued employment through that date. The options had an exercise price of $148.45 per share; 89,820 options were reported following the transaction, with an expiration date of October 31, 2029.
American Express Co. Chief Colleague Exp. Officer Monique Herena had 17,465 performance stock options vest on October 31, 2026, representing the remaining 25% of options granted in October 2022. Vesting was based on performance criteria specified at grant and continued employment through October 31, 2026. The options have an exercise price of $148.45 per share and expire October 31, 2029; her reported post-transaction option position was 69,860 options.
American Express Co. (AXP) Group Pres., U.S. Cons. Serv. Howard Grosfield acquired 17,465 employee stock options on October 31, 2026, representing vesting of the remaining 25% of the Performance Stock Options granted in October 2022. Vesting was based on the award’s performance criteria and continued employment through October 31, 2026. The options have an exercise price of $148.45 per share and expire October 31, 2029. His reported direct option holdings following the transaction were 69,860.